Genomic Aberrations in Lung Adenocarcinoma in Never Smokers-Reference-Cited by-同舟云学术

Genomic Aberrations in Lung Adenocarcinoma in Never Smokers

Published:2010-12-06 Issue:12 Volume:5 Page:e15145
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Job Bastien,Bernheim Alain,Beau-Faller Michèle,Camilleri-Broët Sophie,Girard Philippe,Hofman Paul,Mazières Julien,Toujani Saloua,Lacroix Ludovic,Laffaire Julien,Dessen Philippe,Fouret Pierre,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Lung cancer in never smokers: a review.;J Subramanian;J Clin Oncol,2007

2. Lung cancer in never smokers—a different disease.;S Sun;Nat Rev Cancer,2007

3. Water, air, soil and food pollutants.;Dans:Attibutable Causes of Cancer in France in the Year 2000,2007

4. Lung cancer incidence in never smokers.;HA Wakelee;J Clin Oncol,2007

5. Erlotinib in previously treated non-small-cell lung cancer.;FA Shepherd;N Engl J Med,2005

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China;Thorax;2024-05-03

2. Nuclear protein NOP2 serves as a poor-prognosis predictor of LUAD and aggravates the malignancy of lung adenocarcinoma cells;Functional & Integrative Genomics;2024-03-15

3. Explainable deep learning on 7500 whole genomes elucidates cancer-specific patterns of chromosomal instability;2024-03-13

4. The Configuration of GRB2 in Protein Interaction and Signal Transduction;Biomolecules;2024-02-22

5. Target validation and structure-based virtual screening to Discover potential lead molecules against the oncogenic NSD1 histone methyltransferase;In Silico Pharmacology;2023-08-11